PlainRecalls
FDA Drug Moderate Class II Terminated

MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.

Reported: December 17, 2014 Initiated: September 27, 2012 #D-0295-2015

Product Description

MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.

Reason for Recall

Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
101,200 Vials
Distribution
U.S. Nationwide Including Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.. Recalled by Fresenius Kabi USA, LLC. Units affected: 101,200 Vials.
Why was this product recalled?
Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 17, 2014. Severity: Moderate. Recall number: D-0295-2015.